Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 19.54% is 28% above its 5-year average of 15.23%, near the high end of its 5-year range (-16.48%–28.65%).
14.22% below its 12-month average of 22.78%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 22.59%.
EBITDA MARGIN
19.54%
EBITDA MARGIN AVG TTM
22.78%
EBITDA MARGIN AVG 3Y
21.11%
EBITDA MARGIN AVG 5Y
15.23%
EBITDA MARGIN AVG 10Y
21.33%
EBITDA MARGIN AVG 15Y
24.42%
EBITDA MARGIN AVG 20Y
-78.91%
CURRENT VS TTM AVG
-14.22%
CURRENT VS 3Y AVG
-7.42%
CURRENT VS 5Y AVG
+28.28%
CURRENT VS 10Y AVG
-8.39%
CURRENT VS 15Y AVG
-19.97%
CURRENT VS 20Y AVG
+124.76%
ANI Pharmaceuticals, Inc.
Market Cap
$1.65B
EBITDA Margin
19.54%
TTM Avg
22.78%
3Y Avg
21.11%
5Y Avg
15.23%
Market Cap
$1.65B
EBITDA Margin
0.06%
TTM Avg
-4.29%
3Y Avg
-15.38%
5Y Avg
-22.40%
Market Cap
$1.66B
EBITDA Margin
-164.52%
TTM Avg
-214.39%
3Y Avg
-473.06%
5Y Avg
-473.06%
Market Cap
$1.71B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
Market Cap
$1.76B
EBITDA Margin
1.15%
TTM Avg
-0.80%
3Y Avg
-3.79%
5Y Avg
-4.67%
Market Cap
$1.52B
EBITDA Margin
5.15%
TTM Avg
0.72%
3Y Avg
-7.50%
5Y Avg
-11313.48%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.65B | 19.54% | 22.78% | 21.11% | 15.23% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.06% | -4.29% | -15.38% | -22.40% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | -164.52% | -214.39% | -473.06% | -473.06% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 16.41% | 1.22% | -1.65% | 4.31% |
| Certara, Inc. (CERT)vs › | $1.57B | 18.52% | 17.87% | 16.34% | 15.57% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.15% | -0.80% | -3.79% | -4.67% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 5.15% | 0.72% | -7.50% | -11313.48% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 47.98% | 50.86% | 52.39% | 67.36% |
| GH Research PLC (GHRS)vs › | $1.52B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -628.14% | -766.74% | -948.44% | -801.32% |
Gross Margin
51.0%
EBITDA Margin
19.5%
Operating Margin
15.3%
Net Margin
10.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 22.59% |
| 2026-03-31 | 25.11% |
| 2025-12-31 | 28.65% |
| 2025-09-30 | 19.96% |
| 2025-06-30 | 17.59% |
| 2025-03-31 | 24.90% |
| 2024-12-31 | 9.56% |
| 2024-09-30 | -3.22% |
| 2024-06-30 | 14.39% |
| 2024-03-31 | 25.47% |
| 2023-12-31 | 16.65% |
| 2023-09-30 | 25.15% |
| 2023-06-30 | 23.25% |
| 2023-03-31 | 23.03% |
| 2022-12-31 | 18.46% |
| 2022-09-30 | 12.35% |
| 2022-06-30 | 1.71% |
| 2022-03-31 | -7.19% |
| 2021-12-31 | -16.48% |
| 2021-09-30 | 14.95% |
| 2021-06-30 | -8.70% |
| 2021-03-31 | 25.57% |
| 2020-12-31 | 19.62% |
| 2020-09-30 | 26.73% |
| 2020-06-30 | -0.22% |
| 2020-03-31 | 6.71% |
| 2019-12-31 | 10.20% |
| 2019-09-30 | 32.73% |
| 2019-06-30 | 34.52% |
| 2019-03-31 | 38.77% |
| 2018-12-31 | 35.24% |
| 2018-09-30 | 36.81% |
| 2018-06-30 | 32.95% |
| 2018-03-31 | 31.69% |
| 2017-12-31 | 30.46% |
| 2017-09-30 | 34.11% |
| 2017-06-30 | 31.49% |
| 2017-03-31 | 30.94% |
| 2016-12-31 | 18.61% |
| 2016-09-30 | 36.05% |
| 2016-06-30 | 35.58% |
| 2016-03-31 | 49.99% |
| 2015-12-31 | 46.46% |
| 2015-09-30 | 52.56% |
| 2015-06-30 | 50.36% |
| 2015-03-31 | 57.95% |
| 2014-12-31 | 57.30% |
| 2014-09-30 | 53.98% |
| 2014-06-30 | -26.39% |
| 2014-03-31 | 38.52% |
| 2013-12-31 | 37.00% |
| 2013-09-30 | 15.21% |
| 2013-06-30 | -59.34% |
| 2013-03-31 | -1914.04% |
| 2012-12-31 | -175.88% |
| 2012-09-30 | -4809.81% |
| 2012-06-30 | 128.44% |
| 2012-03-31 | -6053.57% |
| 2011-12-31 | -8976.09% |
| 2011-09-30 | -7108.14% |
| 2011-06-30 | -16078.94% |
| 2011-03-31 | -27652.59% |
| 2010-12-31 | -9222.32% |
| 2010-09-30 | -21461.06% |
| 2010-03-31 | -390.99% |
| 2009-12-31 | -1350.02% |
| 2009-09-30 | -60400.76% |
| 2009-06-30 | -3983.37% |
| 2009-03-31 | -5893.81% |
| 2008-12-31 | -51.24% |
| 2008-09-30 | -8124.21% |
| 2008-06-30 | -21266.40% |
| 2008-03-31 | -8680.05% |
| 2007-12-31 | -608.32% |
| 2007-09-30 | -4861.88% |
| 2007-06-30 | -3747.08% |
| 2007-03-31 | -3666.68% |
| 2006-12-31 | 70.95% |
| 2006-09-30 | -596.35% |
| 2006-06-30 | -1294.11% |
| 2006-03-31 | -3893.78% |
| 2005-12-31 | -1823.41% |
| 2005-09-30 | -2218.15% |
| 2005-06-30 | -5828.29% |
| 2005-03-31 | -9915.60% |
| 2004-12-31 | -7629.54% |
| 2004-09-30 | -27207.03% |
| 2004-06-30 | -52331.53% |
| 2004-03-31 | -33477.56% |
| 2003-12-31 | 3093.72% |
| 2003-09-30 | -5574.55% |
| 2003-03-31 | -1448.33% |
| 2002-12-31 | -21.06% |
| 2002-09-30 | -80.81% |
